Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease.

[1]  Douglas Landsittel,et al.  Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease. , 2012, Clinical journal of the American Society of Nephrology : CJASN.

[2]  J. Felmlee,et al.  Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease. , 2003, Kidney international.

[3]  C. Férec,et al.  The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease. , 2016, Journal of the American Society of Nephrology : JASN.

[4]  B F King,et al.  Quantification and longitudinal trends of kidney, renal cyst, and renal parenchyma volumes in autosomal dominant polycystic kidney disease. , 2000, Journal of the American Society of Nephrology : JASN.

[5]  K. Bae,et al.  A comparison of ultrasound and magnetic resonance imaging shows kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease , 2015, Kidney international.

[6]  Hugues Benoit-Cattin,et al.  Intensity non-uniformity correction in MRI: Existing methods and their validation , 2006, Medical Image Anal..

[7]  Robert M. Haralick,et al.  Textural Features for Image Classification , 1973, IEEE Trans. Syst. Man Cybern..

[8]  A. Cheung,et al.  GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  Daw-Tung Lin,et al.  Computer-aided kidney segmentation on abdominal CT images , 2006, IEEE Transactions on Information Technology in Biomedicine.

[10]  F. Cendes,et al.  Texture analysis of medical images. , 2004, Clinical radiology.

[11]  Oliver Senn,et al.  Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months. , 2009, Kidney international.

[12]  Bradley J Erickson,et al.  Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials. , 2015, Journal of the American Society of Nephrology : JASN.

[13]  Mark Schmidt A Method for Standardizing MR Intensities between Slices and Volumes , 2005 .

[14]  Paul A Thompson,et al.  Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. , 2003, Kidney international.

[15]  Paul A Thompson,et al.  Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort. , 2005, Clinical journal of the American Society of Nephrology : CJASN.

[16]  J. Gore,et al.  Mapping murine diabetic kidney disease using chemical exchange saturation transfer MRI , 2016, Magnetic resonance in medicine.

[17]  Maximilian F Reiser,et al.  MRI-Measurement of Perfusion and Glomerular Filtration in the Human Kidney With a Separable Compartment Model , 2008, Investigative radiology.

[18]  R R Edelman,et al.  Noninvasive evaluation of intrarenal oxygenation with BOLD MRI. , 1996, Circulation.

[19]  Bumwoo Park,et al.  Segmentation of individual renal cysts from MR images in patients with autosomal dominant polycystic kidney disease. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[20]  N. Meinshausen,et al.  Stability selection , 2008, 0809.2932.

[21]  M. Giger,et al.  Volumetric texture analysis of breast lesions on contrast‐enhanced magnetic resonance images , 2007, Magnetic resonance in medicine.

[22]  Brian B. Avants,et al.  Directly Manipulated Free-Form Deformation Image Registration , 2009, IEEE Transactions on Image Processing.

[23]  Imaging end-stage kidney disease in adults: Low-field MR imaging with magnetization transfer vs. ultrasonography , 2000, Acta radiologica.

[24]  Marie E. Edwards,et al.  Semiautomated Segmentation of Polycystic Kidneys in T2-Weighted MR Images. , 2016, AJR. American journal of roentgenology.

[25]  N. Buus,et al.  Reproducibility of MRI renal artery blood flow and BOLD measurements in patients with chronic kidney disease and healthy controls , 2014, Journal of magnetic resonance imaging : JMRI.

[26]  H. Degani,et al.  Functional sodium magnetic resonance imaging of the intact rat kidney. , 2004, Kidney international.

[27]  Henry Rusinek,et al.  New magnetic resonance imaging methods in nephrology , 2013, Kidney international.

[28]  Stefano Severi,et al.  Reliability of Total Renal Volume Computation in Polycystic Kidney Disease From Magnetic Resonance Imaging. , 2015, Academic radiology.

[29]  Jun Xie,et al.  Segmentation of kidney from ultrasound images based on texture and shape priors , 2005, IEEE Transactions on Medical Imaging.

[30]  H. Yoshida,et al.  Wavelet-packet-based texture analysis for differentiation between benign and malignant liver tumours in ultrasound images. , 2003, Physics in medicine and biology.

[31]  B. Kasiske,et al.  Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. , 2015, Kidney international.

[32]  Tso-Jung Yen,et al.  Discussion on "Stability Selection" by Meinshausen and Buhlmann , 2010 .

[33]  Bradley J Erickson,et al.  Automatic total kidney volume measurement on follow-up magnetic resonance images to facilitate monitoring of autosomal dominant polycystic kidney disease progression. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[34]  Hans Stødkilde-Jørgensen,et al.  Validation of quantitative BOLD MRI measurements in kidney: application to unilateral ureteral obstruction. , 2005, Kidney international.

[35]  Alan C. Evans,et al.  A nonparametric method for automatic correction of intensity nonuniformity in MRI data , 1998, IEEE Transactions on Medical Imaging.

[36]  Eiji Higashihara,et al.  Tolvaptan in patients with autosomal dominant polycystic kidney disease. , 2012, The New England journal of medicine.

[37]  P. Prasad,et al.  Blood oxygen level-dependent MR imaging of the kidneys. , 2008, Magnetic resonance imaging clinics of North America.

[38]  A. Levy Diffusion-Weighted MR Imaging of Kidneys in Healthy Volunteers and Patients With Parenchymal Diseases: Initial Experience , 2006 .

[39]  Hersh Chandarana,et al.  Comparison of Biexponential and Monoexponential Model of Diffusion Weighted Imaging in Evaluation of Renal Lesions: Preliminary Experience , 2010, Investigative radiology.

[40]  Behzad Ebrahimi,et al.  Fibrosis detection in renal artery stenosis mouse model using magnetization transfer MRI , 2013, Medical Imaging.

[41]  Lizette Warner,et al.  Noninvasive In Vivo Assessment of Renal Tissue Elasticity During Graded Renal Ischemia Using MR Elastography , 2011, Investigative radiology.

[42]  Bradley J. Erickson,et al.  Utilizing magnetization transfer imaging to investigate tissue remodeling in a murine model of autosomal dominant polycystic kidney disease , 2015, Magnetic resonance in medicine.

[43]  Jing Zhang,et al.  Texture analysis of multiple sclerosis: a comparative study. , 2008, Magnetic resonance imaging.

[44]  Stefano Severi,et al.  Original Report: Patient-oriented, Translational Research Assessment of Kidney Volume in Polycystic Kidney Disease Using Magnetic Resonance Imaging without Contrast Medium , 2022 .

[45]  M. Klein,et al.  Volume Progression in Polycystic Kidney Disease , 2007 .

[46]  Hersh Chandarana,et al.  Intraobserver and interobserver variability of renal volume measurements in polycystic kidney disease using a semiautomated MR segmentation algorithm. , 2012, AJR. American journal of roentgenology.

[47]  Luca Antiga,et al.  Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial , 2013, The Lancet.

[48]  J. Felmlee,et al.  Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[49]  Kaleab Z. Abebe,et al.  Blood pressure in early autosomal dominant polycystic kidney disease. , 2014, The New England journal of medicine.